Sign In
Buy EKSO
$11.80
+0 (+0%)
At Close: Jun 03, 2026
Ekso Bionics Holdings, Inc. (EKSO) Q4 2023 Earnings Call Transcript
08:07pm, Monday, 04'th Mar 2024
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q4 2023 Earnings Conference Call March 4, 2024 4:30 PM ET Company Participants Matt Steinberg - Finn Partners Scott Davis - Chief Executive Officer Jerome Wo
Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates
06:21pm, Monday, 04'th Mar 2024
Ekso Bionics (EKSO) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.24 per share a year ago.
Ekso Bionics Reports Record Annual Revenue of $18.3 Million
04:05pm, Monday, 04'th Mar 2024
Sold Record Number of Annual EksoHealth Units in 2023 SAN RAFAEL, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exosk
Here's Why Ekso Bionics (EKSO) Is a Great 'Buy the Bottom' Stock Now
10:56am, Tuesday, 06'th Feb 2024
Ekso Bionics (EKSO) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean
Best Momentum Stocks to Buy for January 31st
11:01am, Wednesday, 31'st Jan 2024
ADMA, EKSO and IKT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 31, 2024.
New Strong Buy Stocks for January 31st
07:05am, Wednesday, 31'st Jan 2024
ADMA, IKT, YPF, AVXL and EKSO have been added to the Zacks Rank #1 (Strong Buy) List on January 31, 2024.
Why Is Ekso Bionics (EKSO) Stock Up 5% Today?
08:20am, Friday, 26'th Jan 2024
Ekso Bionics (NASDAQ: EKSO ) stock is on the rise Friday without any clear news from the exoskeleton company this morning. There are no new press releases or filings with the Securities and Exchange
Ekso Bionics Launches GaitCoach Software for EksoNR
04:05pm, Monday, 08'th Jan 2024
SAN RAFAEL, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today
Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results
05:05pm, Thursday, 04'th Jan 2024
SAN RAFAEL, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today
SAN RAFAEL, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today
Centers for Medicare & Medicaid Services (CMS) Codifies Medicare Coverage for Ekso Indego Personal
04:01pm, Thursday, 02'nd Nov 2023
Ruling Could Significantly Expand Use of Ekso Indego Personal in Home and Community Markets SAN RAFAEL, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Com
Ekso Bionics (EKSO) Reports Q3 Loss, Tops Revenue Estimates
06:48pm, Thursday, 26'th Oct 2023
Ekso Bionics (EKSO) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.33 per share a year ago.
Ekso Bionics Holdings, Inc. (EKSO) Q3 2023 Earnings Call Transcript
06:23pm, Thursday, 26'th Oct 2023
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q3 2023 Earnings Call October 26, 2023 4:30 PM ET Company Participants Matt Steinberg - Investor Relations Scott Davis - Chief Executive Officer Jason Jones
Ekso Bionics Reports Third Quarter 2023 Revenue Growth of 38%
04:05pm, Thursday, 26'th Oct 2023
SAN RAFAEL, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today
Ekso Bionics to Report Third Quarter 2023 Financial Results on October 26, 2023
04:05pm, Thursday, 19'th Oct 2023
SAN RAFAEL, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today
